Moxibustion alleviates depression-like behavior in rats with Crohn’s disease by inhibiting the kynurenine pathway metabolism in the gut-brain axis
BackgroundMoxibustion is a potential therapy for inflammatory bowel disease-related depression, but its specific mechanism of action is unclear. This study aimed to investigate the molecular mechanism by which moxibustion alleviates depressive behavior in rats with Crohn’s disease (CD).MethodsThe CD...
Main Authors: | Chunhui Bao, Jin Huang, Huangan Wu, Yueying Ma, Hongyu Zhou, Liming Chen, Dandan Yang, Huirong Liu, Yin Shi, Yuan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.1019590/full |
Similar Items
-
Kynurenine acid - metabolism and regulation of kynurenine pathway
by: Piotr Kozłowski, et al.
Published: (2017-07-01) -
Acupuncture and moxibustion therapy for cognitive impairment: the microbiome–gut–brain axis and its role
by: Jiatian Shi, et al.
Published: (2024-01-01) -
Probiotics for inflammatory bowel disease: Is there sufficient evidence?
by: Ma Yueying, et al.
Published: (2024-04-01) -
Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women
by: Monika Turska-Kozłowska, et al.
Published: (2024-03-01) -
Increased Kynurenine Indicates a Fatal Course of COVID-19
by: Harald Mangge, et al.
Published: (2021-12-01)